Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

Clinical trial NCT01198184 · COMPLETED

Trial details

NCT number: NCT01198184
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Endometrial Papillary Serous Carcinoma Recurrent Endometrial Carcinoma Recurrent Renal Cell Cancer Stage III Endometrial Carcinoma Stage III Renal Cell Cancer Stage IV Endometrial Carcinoma Stage IV Renal Cell Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2010-08-01
Primary completion: 2013-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.